TrialBMC cancer2023

Development and validation of prognostic nomograms based on De Ritis ratio and clinicopathological features for patients with stage II/III colorectal cancer.

Jinming Fu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.